Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zasadny, K. R.
Right arrow Articles by Wahl, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zasadny, K. R.
Right arrow Articles by Wahl, R. L.

Radiology, Vol 189, 847-850, Copyright © 1993 by Radiological Society of North America

ARTICLES

Standardized uptake values of normal tissues at PET with 2-[fluorine- 18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction

KR Zasadny and RL Wahl
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0028.

PURPOSE: To study the relationship between standardized uptake values (SUVs) in normal tissues and body weight determined with positron emission tomography (PET). MATERIALS AND METHODS: SUVs were determined in 28 nondiabetic women with newly diagnosed untreated primary breast cancers. Body weights ranged from 45 to 107 kg. SUVs for lung, liver, marrow, spleen, blood, and normal breast were determined from images obtained with PET 50-60 minutes after injection of 2-[fluorine-18]- fluoro-2-deoxy-D-glucose (FDG). RESULTS: There was a positive correlation between SUV and body weight for blood, (r = .75, P = .000004), liver (r = .72, P = .000081), and spleen (r = .57, P = .033), all of which had substantial F-18 activity. In heavy patients, SUVs for those normal tissues were up to twice those of lighter patients. Calculating SUV on the basis of predicted lean body mass (SUV-Lean) eliminated the weight dependence of the SUV for blood (r = .26, P = .18) and reduced weight dependence in other tissues. CONCLUSION: SUV- Lean is a weight-independent index for blood FDG accumulation at PET and may be more appropriate than SUV for quantifying F-18 activity in tumors.


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
J. B. Roedl, M. G. Harisinghani, R. R. Colen, A. J. Fischman, M. A. Blake, D. J. Mathisen, and P. R. Mueller
Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.
Ann. Thorac. Surg., October 1, 2008; 86(4): 1131 - 1138.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
D. S. Boss, R. V. Olmos, M. Sinaasappel, J. H. Beijnen, and J. H. M. Schellens
Application of PET/CT in the Development of Novel Anticancer Drugs
Oncologist, January 1, 2008; 13(1): 25 - 38.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. A. Mankoff, J. F. Eary, J. M. Link, M. Muzi, J. G. Rajendran, A. M. Spence, and K. A. Krohn
Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
Clin. Cancer Res., June 15, 2007; 13(12): 3460 - 3469.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. K. Doot, L. K. Dunnwald, E. K. Schubert, M. Muzi, L. M. Peterson, P. E. Kinahan, B. F. Kurland, and D. A. Mankoff
Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF
J. Nucl. Med., June 1, 2007; 48(6): 920 - 925.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. K. Kim, M. Allen-Auerbach, J. Goldin, B. J. Fueger, M. Dahlbom, M. Brown, J. Czernin, and C. Schiepers
Accuracy of PET/CT in Characterization of Solitary Pulmonary Lesions
J. Nucl. Med., February 1, 2007; 48(2): 214 - 220.
[Abstract] [Full Text] [PDF]

Home page
 Br Med BullHome page
J. D. Berry and G. J. R. Cook
Positron emission tomography in oncology
Br. Med. Bull., December 14, 2006; (2006) ldl013v1.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. A. Thie
Use of Anthropometric Factors in 18F-FDG PET Bone Marrow SUVs
J. Nucl. Med., November 1, 2006; 47(11): 1901 - 1902.
[Full Text] [PDF]

Home page
 JNMHome page
S. Prevost and F. Benard
Reply: Use of Anthropometric Factors in 18F-FDG PET Bone Marrow SUVs
J. Nucl. Med., November 1, 2006; 47(11): 1902 - 1902.
[Full Text] [PDF]

Home page
 JCOHome page
M. Schnall and M. Rosen
Primer on Imaging Technologies for Cancer
J. Clin. Oncol., July 10, 2006; 24(20): 3225 - 3233.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. M. Kenny, D. M. Vigushin, A. Al-Nahhas, S. Osman, S. K. Luthra, S. Shousha, R. C. Coombes, and E. O. Aboagye
Quantification of Cellular Proliferation in Tumor and Normal Tissues of Patients with Breast Cancer by [18F]Fluorothymidine-Positron Emission Tomography Imaging: Evaluation of Analytical Methods
Cancer Res., November 1, 2005; 65(21): 10104 - 10112.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
C. Love, M. B. Tomas, G. G. Tronco, and C. J. Palestro
FDG PET of Infection and Inflammation
RadioGraphics, September 1, 2005; 25(5): 1357 - 1368.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
F. Gutman, J.-L. Alberini, M. Wartski, D. Vilain, E. Le Stanc, F. Sarandi, C. Corone, C. Tainturier, and A. P. Pecking
Incidental Colonic Focal Lesions Detected by FDG PET/CT
Am. J. Roentgenol., August 1, 2005; 185(2): 495 - 500.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
W. A. Weber
Use of PET for Monitoring Cancer Therapy and for Predicting Outcome
J. Nucl. Med., June 1, 2005; 46(6): 983 - 995.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
D. T. Schmid, H. John, R. Zweifel, T. Cservenyak, G. Westera, G. W. Goerres, G. K. von Schulthess, and T. F. Hany
Fluorocholine PET/CT in Patients with Prostate Cancer: Initial Experience
Radiology, May 1, 2005; 235(2): 623 - 628.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. J. Kelloff, J. M. Hoffman, B. Johnson, H. I. Scher, B. A. Siegel, E. Y. Cheng, B. D. Cheson, J. O'Shaughnessy, K. Z. Guyton, D. A. Mankoff, et al.
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Clin. Cancer Res., April 15, 2005; 11(8): 2785 - 2808.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
B. S. Halpern, M. Dahlbom, M. A. Auerbach, C. Schiepers, B. J. Fueger, W. A. Weber, D. H.S. Silverman, O. Ratib, and J. Czernin
Optimizing Imaging Protocols for Overweight and Obese Patients: A Lutetium Orthosilicate PET/CT Study
J. Nucl. Med., April 1, 2005; 46(4): 603 - 607.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Suemasu, and K. Uno
Visual and Semiquantitative Analyses for F-18 Fluorodeoxyglucose PET Scanning in Pulmonary Nodules 1 cm to 3 cm in Size
Ann. Thorac. Surg., March 1, 2005; 79(3): 984 - 988.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
D. L. Chen, M. A. Mintun, and D. P. Schuster
Comparison of Methods to Quantitate 18F-FDG Uptake with PET During Experimental Acute Lung Injury
J. Nucl. Med., September 1, 2004; 45(9): 1583 - 1590.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
H. Kramer, R. M. Pieterman, D.-J. Slebos, W. Timens, W. Vaalburg, G. H. Koeter, and H. J.M. Groen
PET for the Evaluation of Pleural Thickening Observed on CT
J. Nucl. Med., June 1, 2004; 45(6): 995 - 998.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
N. Paquet, A. Albert, J. Foidart, and R. Hustinx
Within-Patient Variability of 18F-FDG: Standardized Uptake Values in Normal Tissues
J. Nucl. Med., May 1, 2004; 45(5): 784 - 788.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
B. S. Halpern, M. Dahlbom, A. Quon, C. Schiepers, C. Waldherr, D. H. Silverman, O. Ratib, and J. Czernin
Impact of Patient Weight and Emission Scan Duration on PET/CT Image Quality and Lesion Detectability
J. Nucl. Med., May 1, 2004; 45(5): 797 - 801.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
H. Schoder, Y. E. Erdi, K. Chao, M. Gonen, S. M. Larson, and H. W.D. Yeung
Clinical Implications of Different Image Reconstruction Parameters for Interpretation of Whole-Body PET Studies in Cancer Patients
J. Nucl. Med., April 1, 2004; 45(4): 559 - 566.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. Tatsumi, C. Cohade, Y. Nakamoto, and R. L. Wahl
Fluorodeoxyglucose Uptake in the Aortic Wall at PET/CT: Possible Finding for Active Atherosclerosis
Radiology, December 1, 2003; 229(3): 831 - 837.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
D. Vranjesevic, C. Schiepers, D. H. Silverman, A. Quon, J. Villalpando, M. Dahlbom, M. E. Phelps, and J. Czernin
Relationship Between 18F-FDG Uptake and Breast Density in Women with Normal Breast Tissue
J. Nucl. Med., August 1, 2003; 44(8): 1238 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. R. de Boer, J. Pruim, B. F.A.M. van der Laan, T. H. Que, A. T.M. Willemsen, F. W.J. Albers, and W. Vaalburg
L-1-11C-Tyrosine PET in Patients with Laryngeal Carcinomas: Comparison of Standardized Uptake Value and Protein Synthesis Rate
J. Nucl. Med., March 1, 2003; 44(3): 341 - 346.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
C. Cohade, M. Osman, H. K. Pannu, and R. L. Wahl
Uptake in Supraclavicular Area Fat ("USA-Fat"): Description on 18F-FDG PET/CT
J. Nucl. Med., February 1, 2003; 44(2): 170 - 176.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
C. Lartizien, C. Comtat, P. E. Kinahan, N. Ferreira, B. Bendriem, and R. Trebossen
Optimization of Injected Dose Based on Noise Equivalent Count Rates for 2- and 3-Dimensional Whole-Body PET
J. Nucl. Med., September 1, 2002; 43(9): 1268 - 1278.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. M. Pieterman, T. H. Que, P. H. Elsinga, J. Pruim, J. W.G. van Putten, A. T.M. Willemsen, W. Vaalburg, and H. J.M. Groen
Comparison of 11C-Choline and 18F-FDG PET in Primary Diagnosis and Staging of Patients with Thoracic Cancer
J. Nucl. Med., February 1, 2002; 43(2): 167 - 172.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Higashi, T. Saga, Y. Nakamoto, T. Ishimori, M. H. Mamede, M. Wada, R. Doi, R. Hosotani, M. Imamura, and J. Konishi
Relationship Between Retention Index in Dual-Phase 18F-FDG PET, and Hexokinase-II and Glucose Transporter-1 Expression in Pancreatic Cancer
J. Nucl. Med., February 1, 2002; 43(2): 173 - 180.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
I. Cranston, L. J. Reed, P. K. Marsden, and S. A. Amiel
Changes in Regional Brain 18F-Fluorodeoxyglucose Uptake at Hypoglycemia in Type 1 Diabetic Men Associated With Hypoglycemia Unawareness and Counter-Regulatory Failure
Diabetes, October 1, 2001; 50(10): 2329 - 2366.
[Abstract] [Full Text]

Home page
 JNMHome page
R. R. Raylman, S. Majewski, A. G. Weisenberger, V. Popov, R. Wojcik, B. Kross, J. S. Schreiman, and H. A. Bishop
Positron Emission Mammography-Guided Breast Biopsy
J. Nucl. Med., June 1, 2001; 42(6): 960 - 966.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J. Aoki, H. Watanabe, T. Shinozaki, K. Takagishi, H. Ishijima, N. Oya, N. Sato, T. Inoue, and K. Endo
FDG PET of Primary Benign and Malignant Bone Tumors: Standardized Uptake Value in 52 Lesions
Radiology, June 1, 2001; 219(3): 774 - 777.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Higashi, S. J. Fisher, R. S. Brown, K. Nakada, G. L. Walter, and R. L. Wahl
Evaluation of the Early Effect of Local Irradiation on Normal Rodent Bone Marrow Metabolism Using FDG: Preclinical PET Studies
J. Nucl. Med., December 1, 2000; 41(12): 2026 - 2035.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
K. Dhital, C. A.B. Saunders, P. T. Seed, M. J. O'Doherty, and J. Dussek
[18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer
Eur. J. Cardiothorac. Surg., October 1, 2000; 18(4): 425 - 428.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Shiozaki, N. Sadato, M. Senda, K. Ishii, T. Tsuchida, Y. Yonekura, H. Fukuda, and J. Konishi
Noninvasive Estimation of FDG Input Function for Quantification of Cerebral Metabolic Rate of Glucose: Optimization and Multicenter Evaluation
J. Nucl. Med., October 1, 2000; 41(10): 1612 - 1618.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
D. B. Schneider, C. Clary-Macy, S. Challa, K. C. Sasse, S. H. Merrick, R. Hawkins, G. Caputo, and D. Jablons
Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma
J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 128 - 133.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. G. Blasberg, U. Roelcke, R. Weinreich, B. Beattie, K. von Ammon, Y. Yonekawa, H. Landolt, I. Guenther, N. E. A. Crompton, P. Vontobel, et al.
Imaging Brain Tumor Proliferative Activity with [124I]Iododeoxyuridine
Cancer Res., February 1, 2000; 60(3): 624 - 635.
[Abstract] [Full Text]

Home page
 RadiologyHome page
Y. Sugawara, K. R. Zasadny, A. W. Neuhoff, and R. L. Wahl
Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction
Radiology, November 1, 1999; 213(2): 521 - 525.
[Abstract] [Full Text]

Home page
 RadiologyHome page
Y. Anzai, S. Minoshima, G. T. Wolf, and R. L. Wahl
Head and Neck Cancer: Detection of Recurrence with Three-dimensional Principal Components Analysis at Dynamic FDG PET
Radiology, July 1, 1999; 212(1): 285 - 290.
[Abstract] [Full Text]

Home page
 RadiologyHome page
Y. Sugawara, K. R. Zasadny, H. B. Grossman, I. R. Francis, M. F. Clarke, and R. L. Wahl
Germ Cell Tumor: Differentiation of Viable Tumor, Mature Teratoma, and Necrotic Tissue with FDG PET and Kinetic Modeling
Radiology, April 1, 1999; 211(1): 249 - 256.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
C. A.B. Saunders, J. E. Dussek, M. J. O'Doherty, and M. N. Maisey
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer
Ann. Thorac. Surg., March 1, 1999; 67(3): 790 - 797.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
P. D. Shreve, Y. Anzai, and R. L. Wahl
Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign Variants
RadioGraphics, January 1, 1999; 19(1): 61 - 77.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W. Romer, A.-R. Hanauske, S. Ziegler, R. Thodtmann, W. Weber, C. Fuchs, W. Enne, M. Herz, C. Nerl, M. Garbrecht, et al.
Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose
Blood, June 15, 1998; 91(12): 4464 - 4471.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1993 by the Radiological Society of North America.